We are monitoring the impact of COVID-19 on IUD Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1029
Share on
Share on

Global Intrauterine Contraceptive Devices Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - Segmented By Product Type and Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1029
Pages: 182

Global Intrauterine Contraceptive Devices Market Size (2021 to 2026)

The global IUD market size is expected to value USD 2034 million by 2026 from USD 1610 million in 2021, growing at a CAGR of 4.78% during the forecast period.

The intrauterine contraceptive is a medical device used to insert into the uterus to avoid the chances of conceiving. The device is used as an emergency contraceptive post to the unwanted sex—two contraceptive devices like copper intrauterine contraceptive devices and hormonal intrauterine contraceptive devices. The medical device is a T-shaped device inserted into the uterus to prevent conception. IUCDs are generally a form of long-acting reversible contraceptives (LARC) assisting in birth control for an enlarged period. As per an article published by a patient, a web-based health information platform, Intrauterine contraceptives devices are cost-effective as 1 to 2 out of every 100 women will conceive after 5 years of using them. Couples or women who don't use IUCDs create and count may reach 80 out of 100 within a year. The demand for these intra-uterine contraceptive devices is significantly growing due to the research and development activities and innovative product launches.

MARKET DRIVERS:

The rise in awareness over the availability of these devices through campaigns and digital advertisements is majorly driving the growth of the IUD Market.

The Intrauterine Devices are small T-shaped devices placed in women’s uterus to prevent pregnancy. Hormone-based copper and hormone-based IUDs are two popular devices in the market. Some of the drivers that propel the Intrauterine Contraceptive Devices market are long-lasting, very good for preventing pregnancy, easy to use and maintain, and cost-effective. Initiative steps by the government in promoting the benefits with the use of IUDs greatly influence the demand of the market.

Additionally, the rise in the number of working-class women across the globe and advancements in the technology of IUDs, increasing the commonness of sexually transmitted diseases, and government funds are some of the other factors fueling the growth of the Global IUD Market.

The emergence of advanced technology and the launch of innovative products create growth opportunities for the market. Even in undeveloped countries, raising awareness of these devices is solely to fuel the market's demand. Also, ongoing research on developing new products is escalating the growth rate of the Intrauterine Contraceptive Devices market.

MARKET RESTRAINS:

Factors that are hampering the market growth are inadequate importance during conception consultations, lack of proper knowledge over the use of the devices in rural areas, pelvic inflammatory infection, infertility issues, ectopic pregnancy, and limited access for conception. Factors like heavy bleeding, irregular bleeding, and cramps are the factors that are likely to sluggish the global intrauterine contraceptive devices market growth.

The shortage of skilled people in healthcare centers is a key challenging factor for the global intrauterine contraceptive devices market players.

Impact of COVID-19 on the global intrauterine contraceptive devices market:

The novel coronavirus has originated in Wuhan, China, and has spread to almost every corner of the world. The World Health Organization (WHO) declared an emergency public health issue in March 2020. The COVID 19 pandemic crisis has created a negative impact on contraceptives and the sexual health market. The primary disturbance is created due to the availability of contraceptives among the people—the decrease in the manufacturing and supply quantities of birth control pills worldwide. The incompetence of millions of men and women across the country to access contraceptives during the lockdown period is foreseen to significantly impact reproductive health indicators, including both maternal and infant mortality rates. The inadequate access to contraceptives over the best scenario case is to exhibit an extra 1.9 million unwanted pregnancies. Worldwide, 50% of pregnancies are unwanted. The intrauterine contraceptive devices market is expected to have significant growth in the coming years. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Product Type and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc, Pfizer.

 

This research report on the global intrauterine contraceptive devices market has been segmented and sub-segmented based on the product type and region.

Intrauterine Contraceptive Devices Market – By Product Type:

  • Hormonal
  • Copper

Based on product type, the Hormonal Intrauterine Contraceptive Devices segment is estimated to have the highest market share since hormonal Intrauterine Contraceptive Devices have fewer complications and risks non-hormonal Intrauterine Contraceptive Devices.

Intrauterine Contraceptive Devices Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America is expected to have the largest share in the global intrauterine contraceptive devices market value. The U.S. is one ruling with the largest shares of the market in this region. A growing number of young women are surging the demand of the market in this region.

Europe is expected to hold the second-largest share value of the IUD market. In this region, the factors driving this region are the rising number of sexually transmitted diseases and growing disposable income in urban areas.

Asia-Pacific is to hold the highest CAGR in the forecast period. India and China are significant countries contributing the highest shares to the market. Growing support from government and non-government organizations through investments in the healthcare center is leveraging the market's demand.

KEY MARKET PLAYERS:

Some of the prominent companies leading the global intrauterine contraceptive devices market profiled in this report are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc., Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd., Okamato Industries, Inc., and Pfizer.

RECENT MARKET DEVELOPMENTS:

  • On February 14, 2020, Twirla, a contraceptive batch launched by Agile Therapeutics has been approved by U.S. FDA. In concern towards public safety, FDA has warned physicians do not to recommend this product for those who suffer from cardiovascular disease.
  • On September 19, 2016, Bayers's intrauterine device, familiarly known as Kyleena, was approved by the U.S. FDA. This device is very useful in preventing pregnancy and has fewer side effects.
  • On May 03, 2016, Allergan launched “LILETTA,” which helps women in the U.S. military. It is an initial step by the company to help military servicewomen, and this product strengthened the company's position in the global intrauterine contraceptive devices market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Hormonal Intrauterine Devices      

                                5.1.2 Copper Intrauterine Devices           

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Mexico     

                                6.4.4 Rest of Latin America         

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Agile Therapeutics                  

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Actavis PLC                 

                8.3 ANI Pharmaceuticals                              

                8.4 Bayer                            

                8.5 Teva Pharmaceutical                              

                8.6 Besins HealthCare                   

                8.7 Brecuro Medical                       

                8.8 Effik International                    

                8.9 Eurogine                      

                8.10 HLL Lifecare                             

                8.11 HRA Pharma                            

                8.12 Lupin Pharmaceuticals                        

                8.13 Okamato Industries                             

                8.14 Pfizer                          

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Market outlook and Investment oppurtunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                         
  2. Global Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                         
  3. Global Hormonal Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                             
  4. Global Copper Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                        
  5. North America Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                         
  6. North America Hormonal Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                             
  7. North America Copper Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                         
  8. United States Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                          
  9. Canada Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                          
  10. Europe Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                          
  11. Europe Hormonal Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                              
  12. Europe Copper Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                       
  13. U.K. Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                             
  14. Germany Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                        
  15. France Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                         
  16. Italy Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                             
  17. Spain Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                          
  18. Asia-Pacific Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                              
  19. Asia-Pacific Hormonal Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                          
  20. Asia-Pacific Copper Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                           
  21. Japan Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                          
  22. China Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                          
  23. India Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                            
  24. Latin America Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                          
  25. Latin America Hormonal Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                        
  26. Latin America Copper Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                          
  27. Brazil Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                           
  28. Rest of Latin America Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                            
  29. Middle East & Africa Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)                             
  30. Middle East & Africa Hormonal Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                       
  31. Middle East & Africa Copper Intrauterine Contraceptive Devices Market, By Region, From 2021 to 2026 (USD Billion)                          
  32. Middle East Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)  
  33. Africa Intrauterine Contraceptive Devices Market, By Product Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample